selenium has been researched along with zidovudine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Jiang, Y; Xu, H; Zhou, J; Zhu, G | 1 |
Berendes, S; Campbell, TB; Cardoso, SW; Christian, P; Gupta, A; Gupte, N; Kanyama, C; Lama, JR; Mwelase, N; Pillay, S; Riviere, C; Samaneka, W; Semba, RD; Shivakoti, R; Sugandhavesa, P; Tang, AM; Yang, WT | 1 |
Ávila, DS; da Silva, RS; de Oliveira Pereira, FS; Leal, JG; Nogara, PA; Rodrigues, OED; Sarturi, JM; Teixeira da Rocha, JB; Viçozzi, GP | 1 |
Augusto Chaves, O; Borba, NRR; Coutinho Souza, DD; da Rocha, JBT; da Rosa, RM; Dornelles, L; Ferreira, VNS; Mayer, JCP; Miranda, MD; Oliveira, TKF; Rocha, NS; Rodrigues, OED; Rosa, AS; Tucci, AR | 1 |
1 trial(s) available for selenium and zidovudine
Article | Year |
---|---|
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Body Mass Index; C-Reactive Protein; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Didanosine; Disease Progression; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Multivariate Analysis; Oligopeptides; Prospective Studies; Pyridines; Risk Factors; Selenium; World Health Organization; Zidovudine | 2014 |
3 other study(ies) available for selenium and zidovudine
Article | Year |
---|---|
Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model.
Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Female; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Selenium; Spleen; Splenomegaly; Superoxide Dismutase; Zidovudine; Zinc | 1997 |
In silico evidences of Mpro inhibition by a series of organochalcogen-AZT derivatives and their safety in Caenorhabditis elegans.
Topics: Animals; Antioxidants; Caenorhabditis elegans; HIV Infections; Humans; SARS-CoV-2; Selenium; Vaccines; Zidovudine | 2023 |
Antiviral Effect of 5'-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection.
Topics: Antiviral Agents; COVID-19; Humans; Molecular Docking Simulation; Papain; Peptide Hydrolases; RNA-Dependent RNA Polymerase; SARS-CoV-2; Selenium; Zidovudine | 2023 |